HCA Healthcare Inc
F:2BH
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
H
|
HCA Healthcare Inc
F:2BH
|
US |
|
Central Pattana PCL
SET:CPN
|
TH |
|
R
|
Resona Holdings Inc
XMUN:DW1
|
JP |
Wall St Price Targets
2BH Price Targets Summary
HCA Healthcare Inc
According to Wall Street analysts, the average 1-year price target for
2BH is 495.92 EUR with a low forecast of 368.55 EUR and a high forecast of 651.91 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 2BH's stock price target?
Price Target
495.92
EUR
According to Wall Street analysts, the average 1-year price target for
2BH is 495.92 EUR with a low forecast of 368.55 EUR and a high forecast of 651.91 EUR.
What is the Revenue forecast for HCA Healthcare Inc?
Projected CAGR
6%
Over the last 13 years, the compound annual growth rate for Revenue has been 7%. The projected CAGR for the next 8 years is 6%.
What is the Gross Profit forecast for HCA Healthcare Inc?
Projected CAGR
-4%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 7%. The projected CAGR for the next 8 years is -4%.
What is the Operating Income forecast for HCA Healthcare Inc?
Projected CAGR
4%
Over the last 13 years, the compound annual growth rate for Operating Income has been 7%. The projected CAGR for the next 8 years is 4%.
What is the Pre-Tax Income forecast for HCA Healthcare Inc?
Projected CAGR
4%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 10%. The projected CAGR for the next 3 years is 4%.
What is the Net Income forecast for HCA Healthcare Inc?
Projected CAGR
5%
Over the last 13 years, the compound annual growth rate for Net Income has been 12%. The projected CAGR for the next 8 years is 5%.